This is a preview of subscription content, log in via an institution to check access.
Reference
Dong OM, et al. Cost-Effectiveness of Multigene Pharmacogenetic Testing in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention. Value in Health : 25 Sep 2019. Available from: URL: https://doi.org/10.1016/j.jval.2019.08.002
Rights and permissions
About this article
Cite this article
Multigene testing in acute coronary syndrome optimises drug therapy. PharmacoEcon Outcomes News 838, 19 (2019). https://doi.org/10.1007/s40274-019-6264-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6264-0